Skip to main content
Fig. 3 | Cardiovascular Diabetology

Fig. 3

From: Countering adipose tissue dysfunction could underlie the superiority of telmisartan in the treatment of obesity-related hypertension

Fig. 3

Effect of telmisartan on lipid profile in diet-induced obesity hypertension. a Serum total cholesterol level in control, DIO and DIO + Tel groups. b Serum triglycerides level in control, DIO and DIO + Tel groups. c Serum low density lipoproteins level in control, DIO and DIO + Tel groups. d Serum very low density lipoproteins level in control, DIO and DIO + Tel groups. e Serum high density lipoproteins level in control, DIO and DIO + Tel groups (number of rats = 10/group. P < 0.05 considered significant, * significant when compared to the control group, • significant when compared to the DIO group)

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840